Zobrazeno 1 - 10 of 34 pro vyhledávání: '"Navin K Chintala"'
1
Akademický článek
Organ-specific heterogeneity in tumor-infiltrating immune cells and cancer antigen expression in primary and autologous metastatic lung adenocarcinoma
Autor: Yan Li, David R Jones, Xiaoyu Li, Prasad S Adusumilli, David Restle, Joseph Dux, Alexander J Byun, Jennie K Choe, Raj G Vaghjiani, Carlos Thomas, Kyohei Misawa, Kay See Tan, Navin K Chintala
Publikováno v: Journal for ImmunoTherapy of Cancer, Vol 11, Iss 6 (2023)
Background Tumor immune microenvironment (TIME) and cancer antigen expression, key factors for the development of immunotherapies, are usually based on the data from primary tumors due to availability of tissue for analysis; data from metastatic site
Externí odkaz: https://doaj.org/article/0417d5e6a51344c8a445b3c12686a2ee
Zobrazit plný text záznamu
2
Akademický článek
Globular C1q Receptor (gC1qR/p32/HABP1) Is Overexpressed in Malignant Pleural Mesothelioma and Is Associated With Increased Survival in Surgical Patients Treated With Chemotherapy
Autor: Xiaoyu Li, Takashi Eguchi, Rania G. Aly, Navin K. Chintala, Kay See Tan, Marjorie G. Zauderer, Francine R. Dembitzer, Mary Beth Beasley, Berhane Ghebrehiwet, Prasad S. Adusumilli, Ellinor I. B. Peerschke
Publikováno v: Frontiers in Oncology, Vol 9 (2019)
Introduction: Globular C1q receptor (gC1qR/p32/HABP1) is overexpressed in a variety of cancers, particularly adenocarcinomas. This study investigated gC1qR expression in malignant pleural mesothelioma (MPM) and its pathophysiologic correlates in a su
Externí odkaz: https://doaj.org/article/09bbfdc3467b497a9c6b8bcb319d9b24
Zobrazit plný text záznamu
10
Correlative analysis from a phase I clinical trial of intrapleural administration of oncolytic vaccinia virus (Olvi-vec) in patients with malignant pleural mesothelioma
Autor: Navin K. Chintala, Jennie K. Choe, Erin McGee, Rebecca Bellis, Jasmeen K. Saini, Srijita Banerjee, Andre L. Moreira, Marjorie G. Zauderer, Prasad S. Adusumilli, Valerie W. Rusch
Publikováno v: Frontiers in Immunology. 14
BackgroundThe attenuated, genetically engineered vaccinia virus has been shown to be a promising oncolytic virus for the treatment of patients with solid tumors, through both direct cytotoxic and immune-activating effects. Whereas systemically admini
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::116eb4419dcd93e9ae9b8c3a4406a0ba
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje